List view / Grid view
Gains access to the company’s small molecule-targeted protein degraders to…
Gains access to the company’s small molecule-targeted protein degraders to expand its oncology pipeline.
The Arctos Medical acquisition will expand Novarits’ optogenetics portfolio to…
The Arctos Medical acquisition will expand Novarits’ optogenetics portfolio to bring gene therapies to patients with severe vision loss.
The Gates Foundation will fund Novartis’ discovery and development of…
The Gates Foundation will fund Novartis’ discovery and development of a gene therapy for sickle cell disease that is accessible for low- and middle-income countries.
